ZBH Filing
4Filing Date: Jun 3, 2026

ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0002059755-26-000006open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

Noor Jehanzeb
See remarks below.·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+1.86K
Price$0.00
Total Value$0
Shares Owned After1.86K
Transaction DateJun 1, 2026
Footnotes ▸

Each RSU represents a contingent right to receive one share of Company common stock. | Vests annually over three years in increments of one-third each year, commencing June 1, 2027. | Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

Post-Transaction Holdings

Noor Jehanzeb
SecuritySharesChange
Restricted Stock Units1.86K+1.86K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ZIMMER BIOMET HOLDINGS, INC. (ZBH) CIK: 0001136869 --- Reporting Owner --- Name: Noor Jehanzeb CIK: 0002059755 Role: Officer (See remarks below.) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-06-01 | Code: A (Grant or award) Shares: +1,857 | Price: $0.00 Shares Owned After: 1,857 | Ownership: D (Direct) Footnotes: [F1] Each RSU represents a contingent right to receive one share of Company common stock. [F2] Vests annually over three years in increments of one-third each year, commencing June 1, 2027. [F2] Vests annually over three years in increments of one-third each year, commencing June 1, 2027. --- Footnotes (Complete Index) --- F1: Each RSU represents a contingent right to receive one share of Company common stock. F2: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. --- Signature --- /s/ /s/ Matthew R. St. Louis, Attorney-in-fact for Jehanzeb Noor (power of attorney previously filed) (2026-06-03)

keid analysis is for reference only and does not constitute investment advice.